Pure Global
NCT06036160

Feasibility of Integrated Care of Depression in Primary Care Pathways

Evaluation de Soins Primaires Intégrés en Psychiatrie
Association De La Msp Pasteur·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Depressive Disorder
Drug/Device/Intervention
Integrated care
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Association De La Msp Pasteur
Timeline & enrollment
Phase
N/A
Start date
Nov 01, 2023
End date
Nov 01, 2026
Enrollment
50 participants
Primary outcome

Percentage of patients completing the study per-protocol

Summary

This protocol is a feasibility study of an integrated primary care pathway for patients
 suffering from difficult-to-treat depression. 50 patients will be recruited and followed for
 two years.

ICD-10 classifications
Depressive conduct disorderRecurrent depressive disorder, unspecifiedRecurrent depressive disorderOther recurrent depressive disordersRecurrent depressive disorder, currently in remission
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06036160
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06036160 through Pure Global AI's free database. This phase not specified trial is sponsored by Association De La Msp Pasteur and is currently Not yet recruiting. The study focuses on Depressive Disorder. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.